Cao X, Cao Z, Ou C, Zhang L, et al. Combination of serum paraoxonase/arylesterase 1 and antithrombin-III is a
promising non-invasion biomarker for discrimination of AFP-negative HCC versus
liver cirrhosis patients. Clin Res Hepatol Gastroenterol 2021;45:101583.
PMID: 33756265